METTL16 and central nervous system cancer: In addition, knockdown of METTL16 significantly enhanced the content of MDA (Figure 10A) and ROS level (Figure 10C), but inhibited GSH level (Figure 10B), suggesting that METTL16 inhibited ferroptosis in glioma cells.